samarium has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abaya, CD; Berenson, JR; Duvivier, H; Mapes, R; Nassir, Y; Patel, R; Swift, RA; Yellin, O | 1 |
| Clunie, G; Cullum, I; Edwards, JC; Ell, PJ; Lui, D | 1 |
1 trial(s) available for samarium and Recrudescence
| Article | Year |
|---|---|
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Drug Administration Schedule; Ethylenediamines; Humans; Maximum Tolerated Dose; Multiple Myeloma; Organophosphonates; Platelet Count; Pyrazines; Radioisotopes; Recurrence; Samarium | 2009 |
1 other study(ies) available for samarium and Recrudescence
| Article | Year |
|---|---|
Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Hydroxyapatites; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Radioisotopes; Recurrence; Samarium; Synovitis; Treatment Outcome | 1996 |